Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 5/20 | 0.66 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.61 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.61 |
| ▸ | GLP1R | P43220 | 4/20 | 0.61 |
| ▸ | NPY2R | P49146 | 7/20 | 0.60 |
| ▸ | NPY4R | P50391 | 7/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.60 |
| ▸ | NPY1R | P25929 | 5/20 | 0.60 |
| ▸ | GCGR | P47871 | 3/20 | 0.59 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.58 |
| ▸ | RAMP2 | O60895 | 1/20 | 0.58 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.58 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.58 |
| ▸ | EP300 | Q09472 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658369 | 0.89 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RGCGR | |
| SCHEMBL30176470 | 0.89 | CALCR (0.73) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL30495828 | 0.88 | CALCR (0.74) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL30658206 | 0.88 | CALCR (0.68) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL30565137 | 0.88 | CALCR (0.76) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL30658283 | 0.87 | CALCR (0.74) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL29462637 | 0.87 | CALCR (0.79) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL31182555 | 0.87 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL29598731 | 0.87 | C5AR1 (0.63) | CALCRGLP1RNPY2RNPY4RNPY5R | |
| SCHEMBL30658223 | 0.87 | CALCR (0.65) | CALCRCRHR1CRHR2GLP1RGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |